Indianapolis, United States
About the Department
The Novo Nordisk Research Center Indianapolis, Inc. (NNRCII) supports our global mission to transform the treatment of chronic diseases through the discovery of high-quality drug candidates and disruptive technology innovations. We operate as a Transformational Research Unit (TRU), meaning we are a relatively small team of elite interdisciplinary researchers working in unison yet with autonomy relative to the global R&D organization—essentially a biotech-like ecosystem within the Novo Nordisk biosphere. We have multiple strategic collaborations with internationally acclaimed academic centers of excellence and emerging biotech’s, which we view as an integral part of our discovery research process and essential for our fundamental scientific endeavors. Collectively, this allows us to focus our efforts on data generation and translation of research hypotheses to foster quick data-driven, non-stochastic decisions.
We are keenly focused on grassroot discovery projects pertaining to cardio-metabolic diseases and rare endocrine disorders, and we are responsible for driving projects from ideation to clinical development. In addition to drug discovery research, we also explore novel chemical biology technologies to optimize the therapeutic applications of peptides/proteins as well as biotechnologies that catalyze the pursuits of therapeutic modalities new to Novo Nordisk. Are you ready to make a difference?
The Scientist II will provide scientific leadership in the identification and validation of new drug targets, advancing novel therapies to the clinic, and developing technologies to accelerate drug research. This will be achieved by coordinating multiple research activities involving cross-functional project teams to ensure achievement of key deliverables. The Scientist II will represent the organization to the external scientific community through publication and presentation of research and through participation in external collaborations.
Reports to of the Site Head of Novo Nordisk Research Center
Indianapolis & Senior Director of the Transformational
Research Unit-Chemical Biology.
Internal relationships include project teams and research colleagues in Seattle, Indianapolis, Denmark, and around the globe. Communicates data externally when required. May oversee parts of discovery research chemistry operations and laboratory facilities. May manage external collaborations with academic and industry partners. Individual Contributor: does not manage other employees or contingent workers.
Novo Nordisk requires all employees, both Field and Office-based, to be fully vaccinated with a COVID-19 vaccine prior to the first date of employment. As required by applicable law, Novo Nordisk will consider requests for reasonable accommodation for those unable to be vaccinated. You will be required to upload an image of your COVID-19 vaccine card at the time of hire and/or on your first day of employment
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.
If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.